Format
Items per page

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Epithelial Neoplasm

A benign or malignant neoplasm that arises from and is composed of epithelial cells. This category include adenomas, papillomas, and carcinomas. [from NCI]

MedGen UID:
277963
Concept ID:
C1368683
Neoplastic Process
2.

Antral

MedGen UID:
85322
Concept ID:
C0293352
Organic Chemical; Pharmacologic Substance
3.

Atrophy

Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. [from MeSH]

MedGen UID:
83084
Concept ID:
C0333641
Pathologic Function
4.

Ulcer

Destruction of an epithelial surface extending into or beyond the basement membrane. [from NCI_CDISC]

MedGen UID:
22541
Concept ID:
C0041582
Disease or Syndrome
5.

Acetic Acid

A synthetic carboxylic acid with antibacterial and antifungal properties. Although its mechanism of action is not fully known, undissociated acetic acid may enhance lipid solubility allowing increased fatty acid accumulation on the cell membrane or in other cell wall structures. Acetic acid, as a weak acid, can inhibit carbohydrate metabolism resulting in subsequent death of the organism. [from NCI]

MedGen UID:
7835
Concept ID:
C0000983
Indicator, Reagent, or Diagnostic Aid; Organic Chemical; Pharmacologic Substance
6.

Metaplasia

A condition in which there is a change of one adult cell type to another similar adult cell type. [from MeSH]

MedGen UID:
7571
Concept ID:
C0025568
Cell or Molecular Dysfunction
7.

Ulceration

The formation or development of an ulcer. [from NCI]

MedGen UID:
854391
Concept ID:
C3887532
Pathologic Function
8.

Antral ulcer

MedGen UID:
810778
Concept ID:
C1112576
Disease or Syndrome
9.

Visual Suppression

MedGen UID:
526147
Concept ID:
C0221103
Pathologic Function
10.

Tumor Suppression

Tumor suppression involves inhibition of tumor cell growth, proliferation, malignancy, or metastasis. [from NCI]

MedGen UID:
274321
Concept ID:
C1519692
Molecular Function
11.

Severe dysplasia

A morphologic finding indicating the presence of severe cellular atypia associated with severe architectural changes in a tissue sample. [from NCI]

MedGen UID:
137715
Concept ID:
C0334048
Cell or Molecular Dysfunction
12.

Chronic

Slow, creeping onset, slow progress and long continuance of disease manifestations. [from HPO]

MedGen UID:
104657
Concept ID:
C0205191
Temporal Concept
13.

Severe

Having a high degree of severity. For quantitative traits, a deviation of between four and five standard deviations from the appropriate population mean. [from HPO]

MedGen UID:
104640
Concept ID:
C0205082
Qualitative Concept
14.

Localized

Being confined or restricted to a particular location. [from HPO]

MedGen UID:
98236
Concept ID:
C0392752
Spatial Concept
15.

Dysplasia

A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns. The cellular changes include nuclear and cytoplasmic abnormalities. Molecular genetic abnormalities are also often found and, in some instances, may lead to cancer. [from NCI]

MedGen UID:
87191
Concept ID:
C0334044
Pathologic Function
16.

Intestinal metaplasia

A morphologic finding indicating the replacement of epithelial tissue outside the intestines by intestinal-type epithelium. [from NCI]

MedGen UID:
83105
Concept ID:
C0334037
Cell or Molecular Dysfunction
17.

Growth substance

Signal molecules that are involved in the control of cell growth and differentiation. [from MeSH]

MedGen UID:
315661
Concept ID:
C1812630
Biologically Active Substance; Pharmacologic Substance
18.

Carcinomatosis

Carcinoma that has spread diffusely to an anatomic site or throughout the body. [from NCI]

MedGen UID:
104704
Concept ID:
C0205699
Neoplastic Process
19.

Cribriform Carcinoma

A carcinoma characterized by the presence of a cribriform architectural pattern. Representative examples include the intraductal cribriform breast carcinoma and invasive cribriform breast carcinoma. [from NCI]

MedGen UID:
104694
Concept ID:
C0205643
Neoplastic Process
20.

Mediator of inflammation

The endogenous compounds that mediate inflammation (AUTACOIDS) and related exogenous compounds including the synthetic prostaglandins (PROSTAGLANDINS, SYNTHETIC). [from MeSH]

MedGen UID:
66209
Concept ID:
C0243042
Pharmacologic Substance
Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center